Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001404644-25-000012
Filing Date
2025-03-24
Accepted
2025-03-24 16:04:21
Documents
130
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ngne-20241231.htm   iXBRL 10-K 2415173
2 EX-10.20 a2023equityincentiveplanis.htm EX-10.20 45519
3 EX-10.21 a2023equityincentiveplannq.htm EX-10.21 44816
4 EX-10.22 a2023equityincentiveplanfo.htm EX-10.22 46975
5 EX-10.29 neurogeneemploymentagreeme.htm EX-10.29 80797
6 EX-19.1 ngne-insidertradingpolicyx.htm EX-19.1 91587
7 EX-23.1 exhibit231-consentofdeloit.htm EX-23.1 2391
8 EX-31.1 ngne-2024form10xkxex311peo.htm EX-31.1 9875
9 EX-31.2 ngne-2024form10xkxex312pfo.htm EX-31.2 9971
10 EX-32.1 ngne-2024form10xkxex321.htm EX-32.1 7264
16 image_0.jpg GRAPHIC 44673
17 ngne-20241231_g1.jpg GRAPHIC 18348
18 ngne-20241231_g10.jpg GRAPHIC 26399
19 ngne-20241231_g11.jpg GRAPHIC 57295
20 ngne-20241231_g12.jpg GRAPHIC 17940
21 ngne-20241231_g13.jpg GRAPHIC 17789
22 ngne-20241231_g14.jpg GRAPHIC 15176
23 ngne-20241231_g15.jpg GRAPHIC 19914
24 ngne-20241231_g16.jpg GRAPHIC 25181
25 ngne-20241231_g2.jpg GRAPHIC 19496
26 ngne-20241231_g3.jpg GRAPHIC 4810
27 ngne-20241231_g4.jpg GRAPHIC 21257
28 ngne-20241231_g5.jpg GRAPHIC 26977
29 ngne-20241231_g6.jpg GRAPHIC 17361
30 ngne-20241231_g7.jpg GRAPHIC 7797
31 ngne-20241231_g8.jpg GRAPHIC 23719
32 ngne-20241231_g9.jpg GRAPHIC 26414
  Complete submission text file 0001404644-25-000012.txt   12267891

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20241231.xsd EX-101.SCH 78695
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngne-20241231_cal.xml EX-101.CAL 94922
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngne-20241231_def.xml EX-101.DEF 358388
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20241231_lab.xml EX-101.LAB 917692
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20241231_pre.xml EX-101.PRE 666690
133 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20241231_htm.xml XML 1352546
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36327 | Film No.: 25764119
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)